Search hospitals > Texas > Dallas
Parkland Memorial Hospital
Claim this profileDallas, Texas 75235
Global Leader in Lung Cancer
Global Leader in Ovarian Cancer
Conducts research for Uterine Cancer
Conducts research for Breast Cancer
Conducts research for Fallopian Tube Cancer
236 reported clinical trials
28 medical researchers
Summary
Parkland Memorial Hospital is a medical facility located in Dallas, Texas. This center is recognized for care of Lung Cancer, Ovarian Cancer, Uterine Cancer, Breast Cancer, Fallopian Tube Cancer and other specialties. Parkland Memorial Hospital is involved with conducting 236 clinical trials across 474 conditions. There are 28 research doctors associated with this hospital, such as David Miller, MD, Syed M. Kazmi, Suzanne M. Cole, and David Gerber, MD.Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
Stage II
2Ovarian Cancer
Global LeaderBRCA1 positive
Stage IV
Stage III
Top PIs
David Miller, MDParkland Memorial Hospital3 years of reported clinical research
Studies Ovarian Cancer
Studies Cervical Cancer
21 reported clinical trials
40 drugs studied
Syed M. KazmiUT Southwestern/Simmons Cancer Center-Dallas8 years of reported clinical research
Studies Colon Cancer
Studies Colorectal Cancer
17 reported clinical trials
33 drugs studied
Suzanne M. ColeUT Southwestern/Simmons Cancer Center-Dallas5 years of reported clinical research
Studies Bladder Cancer
Studies Kidney Cancer
16 reported clinical trials
38 drugs studied
David Gerber, MDUT Southwestern/Simmons Cancer Center-Dallas11 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
9 reported clinical trials
16 drugs studied
Clinical Trials running at Parkland Memorial Hospital
Lung Cancer
Prostate Cancer
Ovarian Cancer
Uterine Cancer
Esophageal cancer
Pancreatic Carcinoma
Bladder Cancer
Testicular cancer
Breast Cancer
Gastric cancer
Chemotherapy + Immunotherapy vs. Immunotherapy
for Advanced Lung Cancer
This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.
Recruiting2 awards Phase 3
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Parkland Memorial Hospital?
Parkland Memorial Hospital is a medical facility located in Dallas, Texas. This center is recognized for care of Lung Cancer, Ovarian Cancer, Uterine Cancer, Breast Cancer, Fallopian Tube Cancer and other specialties. Parkland Memorial Hospital is involved with conducting 236 clinical trials across 474 conditions. There are 28 research doctors associated with this hospital, such as David Miller, MD, Syed M. Kazmi, Suzanne M. Cole, and David Gerber, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.